Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 4, 2004, Pages 1182-1187

  Berk, Richard S ^a   Dong, Zhong ^a   Alousi, Sarah ^a   Kosir, Mary Ann ^a,b   Wang, Yuying ^a,b   Vlodavsky, Israel ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARANASE; BETA GLUCURONIDASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA EPITHELIUM; EYE INFECTION; GENE; IMMUNIZATION; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; KERATITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; STAINING; UPREGULATION; ANIMAL; BACTERIAL EYE INFECTION; C57BL MOUSE; CORNEA; CORNEA ULCER; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GRAM NEGATIVE INFECTION; IMMUNOBLOTTING; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; RETINA;

ANIMALS; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONIDASE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; PSEUDOMONAS INFECTIONS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 2142703731     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0589     Document Type: Article

References (41)

1. Oosta GM, Favreau LV, Beeler DL, Rosenberg RD. Purification and properties of human platelet heparitinase. J Biol Chem. 1982;257:11249-11255.
2. Hoogewerf AJ, Leone JW, Reardon IM, et al. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem. 1995;270:3268-3277.
3. Freeman C, Parish CR. Human platelet heparanase: purification, characterization and catalytic activity. Biochem J. 1998;330:1341-1350.
4. Jin L, Nakajima M, Nicolson GL. Immunochemical localization of heparanase in mouse and human melanomas. Int J Cancer. 1990;45:1088-1095.
5. Bame KJ, Hassall A, Sanderson C, Venkatesan I, Sun C. Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases. Biochem J. 1998;336:191-200.
6. Bame KJ, Venkatesan I, Dehdashti J, McFarlane J, Burfeind R. Characterization of a novel intracellular heparanase that has a FERM domain. Biochem J. 2002;364:265-274.
7. Mollinedo F, Nakajima M, Llorens A, et al. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J. 1997;327:917-923.
8. Haimov-Kochman R, Friedmann Y, et al. Localization of heparanase in normal and pathological human placenta. Mol Hum Reprod. 2002;8:566-573.
9. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biophys Biochem Acta. 2001;1471:M99-M108.
10. Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001;108:341-347.
11. Fairbanks MB, Mildner AM, Leone JW, et al. Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J Biol Chem. 1999;274:29587-29590.
12. Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999;5:793-802.
13. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR. Cloning of mammalian heparanase an important enzyme in tumor invasion and metastasis. Nat Med. 1999;5:803-809.
14. Kussie PH, Hulmes JD, Ludwig DL, et al. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun. 1999;261:183-187.
15. McKenzie E, Tyson K, Stamps A, et al. Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun. 2000;276:1170-1177.
16. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J Clin Invest. 1992;90:2013-2021.
17. Preston MJ, Kernacki K, Berk RS. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa. Infect Immun. 1993;61:2713-2716.
18. Kreger AS, Lyerly DM, Hazlett LD, Berk RS. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis: vaccination with lipopolysaccharide endotoxins and proteases. Invest Ophthalmol Vis Sci. 1986;27:932-936.
19. Dong Z, Katar M, Linebaugh BE, Sloane BF, Berk RS. Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa. Eur J Biochem. 2001;268:6408-6416.
20. Brown D, Chwa M, Escobar M, Kenney MC. Characterization of the major matrix degrading metalloproteinase of human corneal stroma: evidence for an enzyme/inhibitor complex. Exp Eye Res. 1991;52:5-16.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
22. Hazlett LD, Zucker M, Berk RS. Distribution and kinetics of the inflammatory cell response to ocular challenge with Pseudomonas aeruginosa in susceptible versus resistant mice. Ophthalmic Res. 1992;24:32-39.
23. Kernacki KA, Berk RS. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 1995;36:16-23.
24. Kernacki KA, Berk RS. Characterization of the inflammatory response induced by corneal infection with Pseudomonas aeruginosa. J Ocular Pharmacol. 1994;10:281-288.
25. Kernacki KA, Fridman R, Hazlett LD, Lande MA, Berk RS. In vivo characterization of host and bacterial protease responses during Pseudomonas aeruginosa corneal infections in naïve and immunized animals. Curr Eye Res. 1997;16:289-297.
26. Dong Z, Ghabrial M, Katar M, Fridman R, Berk RS. Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 2000;41:4189-4194.
27. Berk RS, Katar M, Dong Z, Day DE. Plasminogen activators and inhibitors in the corneas of mice infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 2001;42:1561-1567.
28. Dong Z, Katar M, Alousi S, Berk RS. Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa. Invest Ophthalmol Vis Sci. 2001;42:3223-3227.
29. Vlodavsky I, Eldor O, Haimovitz-Friedman A, et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invas Metastasis. 1992;12:112-127.
30. Webb LMC, Ehrengruber MU, Clark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA. 1993;90:7158-7162.
31. Kainulainen V, Wang H, Schick C, Bernfield M. Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem. 1998;273:11563-11569.
32. Park PW, Pier GB, Preston MJ, Goldberger O, Fitzgerald ML, Bernfield M. Syndecan-1 shedding is enhanced by LasA a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem. 2000;275:3057-3062.
33. Park PW, Pier GB, Hinkes MT, Bernfield M. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature. 2001;411:98-102.
34. Miao H.-Q, Qrnitz DM, Eingorn E, Ben-Sasson SA, Vlodavsky I. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J Clin Invest. 1997;99:1565-1575.
35. Elkin M, Ilan N, Ishai-Michaeli R, et al. Heparanase as mediator of angiogenesis: mode of action. FASEB J. 2001;15:1661-1663.
36. Pillarisetti S, Paka L, Sasaki A, et al. Endothelial cell heparanase modulation of lipo-protein lipase activity. J Biol Chem. 1997;272:15753-15759.
37. Ragsdale CG, Castor CW, Roberts DJ, Swartz KH. Connective tissue activating peptide. III. Induction of synthesis and secretion of plasminogen activator by synovial fibroblasts. Arthritis Rheum. 1984;27:663-667.
38. Korner G, Bjornsson TD, Vlodavsky I. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. J Cell Physiol. 1993;154:456-465.
39. Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 1997;272:14713-14720.
40. Inatani M, Honjo M, Ochira A, et al. Spatiotemporal expression patterns of N-syndecan, a transmembrane heparan sulfate proteoglycan, in developing retina. Invest Ophthalmol Vis Sci. 2002;43:1616-1621.
41. Kosir MA, Foley-Loudon PA, Finkenauer R, Tennenberg SD. Multiple heparanases are expressed in polymorphonuclear cells. J Surg Res. 2002;103:100-108.